Acute cytotoxic effects of the pharmaceutical excipients benzalkonium chloride (BAC), macrogolglycerol hydroxystearate (MGHS40), polysorbate 80 (PS80) and marketed ophthalmic formulations (Lumigan(R), Monoprost(R), Taflotan(R), Travatan(R), Xalatan(R)) containing these excipients were tested.
Human corneal epithelial cell (HCE-T) viability was assessed by measuring the reduction of resazurin to highly fluorescent resorufin.
The study was fully funded by Experimentica Ltd.
Subscribe to Our Newsletter!
We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers to!